Can FTC, state lawsuit pressure Hims & Hers Health stock?

Traders Union
All News
Stocks
Hims & Hers Health slides 7.99% today

Highlights

Hims & Hers Health faces legal action from federal and state authorities over alleged deceptive billing and improper data sharing, increasing legal and regulatory risk.
Visa placed Hims & Hers Health into its Acquirer Monitoring Program due to excessive customer complaints, resulting in added penalty costs and heightened scrutiny.
Shares of Hims & Hers Health dropped 7.99% to $31.08, with indicators showing near-term bearish pressure and a projected price range of $27.95 to $34.21.

Legal and regulatory scrutiny intensifies as lawsuits and investigations mount

Hims & Hers Health faced a lawsuit from the Federal Trade Commission and state authorities on July 29, 2026, alleging deceptive billing practices, difficulties in subscription cancellation, and improper sharing of consumer health data, according to Kalkinemedia. This development introduced immediate legal risk, reputational concerns, and the potential for significant penalties, which have weighed on investor sentiment. Additional pressure arose as Visa placed Hims & Hers Health into its Acquirer Monitoring Program for excessive customer complaints, resulting in further penalty costs amid mounting regulatory scrutiny, as highlighted by Marketbeat. Law firms Kaplan Fox & Kilsheimer LLP and the Law Offices of Frank R. Cruz also opened investigations into possible securities law violations, amplifying legal uncertainty.

Mixed momentum and bearish indicators weigh against near-term resistance

Technically, HIMS is trading below its MA-20 at $32.26 but remains above the MA-50 at $30.18 and the MA-200 at $28.83. The Ichimoku Kijun at $31.79 marks immediate resistance. Momentum indicators are mixed: MACD points to strong buy momentum, while ADX shows a sell bias. The RSI sits at 46.96 with a "Sell" reading, and CCI aligns with a bearish signal. Both Stoch RSI and Bull/Bear Power are oversold, reflecting seller dominance, while the Awesome Oscillator supports the negative momentum bias.

Volatility expected as breakout hinges on resistance and support levels

In the short term, HIMS is projected to fluctuate within a range of $27.95 to $34.21. The probability of an upward move is estimated at 57%, with the base case anticipating sideways trading inside this volatility band. A bullish scenario would require a decisive break and sustained move above the immediate $31.79 resistance. Conversely, a drop below the $27.95 support zone would trigger a bearish shift.

Anton Kharitonov, analyst at Traders Union, sees Hims & Hers Health under pressure from significant legal and regulatory risks. He notes that negative news flow and additional penalties are weighing on sentiment, while technicals show negative momentum with major resistance at $31.79. The base case is for range-bound trading unless key levels are broken. "Until the immediate legal headwinds ease and price reclaims $31.79, I remain cautious on HIMS."

Earlier, analysts noted that Hims & Hers Health maintained a bullish technical structure supported by an ongoing uptrend, with caution advised due to emerging regulatory risks and potential overbought conditions. The current escalation of legal and compliance challenges adds further downside risk, making sustained price action above the $31.79 resistance a critical signal for any near-term technical reversal.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.